• Published 2005

The use of antineutrophil cytoplasmic antibodies in the diagnosis and monitoring of small vessel vasculitis

@inproceedings{Vervaeke2005TheUO,
  title={The use of antineutrophil cytoplasmic antibodies in the diagnosis and monitoring of small vessel vasculitis},
  author={Steven Vervaeke},
  year={2005}
}
Antineutrophil cytoplasmic antibodies (ANCA) are useful markers in the diagnosis of small vessel vasculitis, such as Wegener’s granulomatosis and microscopic polyangiitis. However, the diagnostic value of ANCA depends largely on the pretest probability of small vessel vasculitis. If a patient presents with little clinical evidence of a small vessel vasculitis, the diagnostic probability of ANCA-associated vasculitis remains low, despite a positive ANCA result. Guidelines are necessary to… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Clinical applications of antineutrophil cytoplasmic antibody testing

WH Schmitt, FJ vanderWoude
  • Curr Opin Rheumatol
  • 2004

ANCA are pathogenic--oh yes they are!

  • Journal of the American Society of Nephrology : JASN
  • 2002

Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis.

  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2002